2Riska A, Leminen A, Pukkala E. Sociodemographic determinants of incidence of primary fallopian tube carcinoma. Finland 1953-9[J].IntJ Cancer, 2003, 104(5): 643-645.
3Pectasides D, Pectasides E, Economopoulos T. Fallopian tube carcinoma: a review[J]. Oncologist, 2006, 11 (8): 902-912.
4Clayton NL, Jaaback KS, Hirschowitz L. Primary fallopian tube carcinoma - the experience of a UK cancer centre and a review of the literature[J], J Obstet Gynaecol, 2005, 25 (7): 694-702.
5Aziz S, Kuperstein G, Rosen B, et al. A genetic epidemiological study of carcinoma of the fallopian tube[J].Gynecol Oncol, 2001, 80(3): 341-345.
6Riska A, Leminen A. Updating on primary fallopian tube carcinoma[J]. Acta Obstet Gynecol Scand, 2007, 86 (12): 1419-1426.
7Goswami PK, Kerr-Wilson R, McCarthy K. Cancer of the fallopian tube[J]. Obstet Gynaecol, 2006, 8: 147-152.
8Hefler LA, Rosen AC, Graf AH, et al. The clinical value of serum concentrations of cancer antigen 125 in patients with primary fallopian tube carcinoma: a multicenter study[J]. Cancer, 2000, 89 (7): 1555-1560.
9Colakovic S, Lukic V, Mitrovic L, et al. Prognostic value of CA125 kinetics and half-fife in advanced ovarian cancer[J]. IntJ Biol Markers, 2000,15(2): 147-152.
10Baekelandt M, Jorunn Nesbakken A, Kristensen GB, et al. Carcinoma of the fallopian mbe[J]. Cancer, 2000, 89(10): 2076-2084.
